Hyaluronate and Derivatives and Polycitra-LC
Determining the interaction of Hyaluronate and Derivatives and Polycitra-LC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hyaluronan
Brand name: Hymovis, Monovisc, Orthovisc, Hydase
Synonyms: Hyaluronan
Generic Name: citric acid / potassium citrate / sodium citrate
Brand name: Cytra-3, Polycitra, Polycitra-LC, Tricitrates, Virtrate-3
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hyaluronate and Derivatives-Polyethylene Glycol 3350 NF PEGYLAX
- Hyaluronate and Derivatives-Polyethylene Glycol
- Hyaluronate and Derivatives-Polyethylene glycol 3350
- Hyaluronate and Derivatives-Polyethylene glycol 3350 and electrolytes
- Hyaluronate and Derivatives-Polyethylene glycol 3350, electrolytes, and ascorbic acid
- Hyaluronate and Derivatives-Polyethylene glycol 3350, sodium and potassium salts
- Polycitra-LC-Hyaluronate and Derivatives Injection (Knee)
- Polycitra-LC-Hyaluronate sodium Injection
- Polycitra-LC-Hyaluronidase
- Polycitra-LC-Hyaluronidase and immune globulin
- Polycitra-LC-Hyaluronidase and rituximab
- Polycitra-LC-Hyaluronidase and trastuzumab